Cargando...
Design Considerations for Dose-Expansion Cohorts in Phase I Trials
Phase I trials are increasingly including dose-expansion cohorts after the maximum-tolerated dose (MTD) has been reached to better characterize the toxicity profile or identify early signs of efficacy within a specific disease population. This article provides guidelines on how to monitor safety and...
Guardado en:
| Publicado en: | J Clin Oncol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society of Clinical Oncology
2013
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979131/ https://ncbi.nlm.nih.gov/pubmed/24101039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.47.9949 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|